GSA CAPITAL PARTNERS LLP - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 145 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.3%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2023$205
+253.4%
70,518
+300.8%
0.02%
+185.7%
Q4 2022$58
-100.0%
17,595
-68.1%
0.01%
-75.0%
Q3 2022$209,000
+56.0%
55,208
+281.6%
0.03%
+55.6%
Q1 2022$134,000
-65.1%
14,466
-40.7%
0.02%
-62.5%
Q4 2021$384,000
+105.3%
24,381
+87.5%
0.05%
+54.8%
Q1 2021$187,00013,0010.03%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Antipodean Advisors LLC 1,000,000$1,480,0007.58%
Redmile Group, LLC 6,280,813$9,295,6030.44%
Arctis Global LLC 397,046$587,6280.32%
Baupost Group 9,773,616$14,4650.28%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 230,000$413,4000.24%
MAVERICK CAPITAL LTD 6,290,713$9,310,2550.21%
683 Capital Management, LLC 1,200,000$1,776,0000.14%
STALEY CAPITAL ADVISERS INC 1,000,000$1,480,0000.08%
WASATCH ADVISORS LP 8,399,229$12,430,8590.08%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 525,000$777,0000.07%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders